Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Case series and a review of the literature
- PMID: 30593169
- PMCID: PMC6314763
- DOI: 10.1097/MD.0000000000013806
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Case series and a review of the literature
Abstract
Rationale: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare idiopathic disease with only about 100 cases reported in the literature.
Patient concerns: Here, we presented 4 cases of DIPNECH. Four patients included 2 females and 2 males, aged 54 to 64 years old; 3 had no smoking history and 1 had history of smoking for 30 years. Surgical resection was performed for every patient. Cases 1 and 3 did not receive postoperative chemotherapy or radiotherapy, and case 2 received 4 times of postoperative chemotherapy. Case 4 just finished the operation and after a period of time, he will receive postoperative chemotherapy.
Diagnoses: Case 1: A 57-year-old female had chest pain, and computer tomography (CT) examination prompted a mass shadow of left lung lower lobe. Case 2: A 64-year-old female had cough and expectoration for more than 1 month. CT examination showed: a lump with diameter of about 2.5 cm and irregular edge was in right lung upper lobe, being largely possibly lung cancer. Case 3: A 54-year-old male, CT examination accidentally found a long strip-shaped nodule in left lung oblique fissure when checkup's, and he had no fever, cough, expectoration, chest tightness, or chest pain. Case 4: A 61-year-old male, checkup's CT examination accidentally found a nodule, fibrosis, bronchiectasis, and secondary infection in the left lower lobe. Combined with pathological morphology and immunohistochemistry, cases 1 and 3 were diagnosed as DIPNECH with multiple carcinoid tumorlet formation and chronic inflammation and bronchiectasis, case 2 was diagnosed as an adenocarcinoma with DIPNECH and multiple carcinoid tumorlet formation, case 4 was diagnosed as an adenocarcinoma with DIPNECH and multiple carcinoid tumorlet formation and chronic inflammation and bronchiectasis.
Interventions: Surgical resection was performed for every patient. Cases 1 and 3 did not receive postoperative chemotherapy or radiotherapy, and case 2 received 4 times of postoperative chemotherapy. Case 4 just finished the operation and after a period of time, he will receive postoperative chemotherapy.
Outcomes: Four patients have been followed up and have had good condition.
Lessons: DIPNECH is often found accidentally in a surgical specimen, is easily missed, and needs careful observation. Immunohistochemistry is necessary to make this diagnosis.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures





Similar articles
-
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Case Report and Review of the Literature.Am J Case Rep. 2017 Sep 11;18:975-979. doi: 10.12659/ajcr.904468. Am J Case Rep. 2017. PMID: 28890532 Free PMC article. Review.
-
[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (dipnech) - an overview of the cases diagnosed at the department of thoracic surgery in the years 2010-2014].Wiad Lek. 2017;70(5):1005-1012. Wiad Lek. 2017. PMID: 29203758 Polish.
-
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.Lung. 2015 Oct;193(5):659-67. doi: 10.1007/s00408-015-9755-1. Epub 2015 Jun 24. Lung. 2015. PMID: 26104490
-
[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)].Rev Mal Respir. 2025 May;42(5):262-273. doi: 10.1016/j.rmr.2025.03.001. Epub 2025 Mar 27. Rev Mal Respir. 2025. PMID: 40155277 Review. French.
-
[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in a 67-year-old patient with chronic coughing].Dtsch Med Wochenschr. 2014 Jun;139(23):1245-8. doi: 10.1055/s-0034-1370073. Epub 2014 May 27. Dtsch Med Wochenschr. 2014. PMID: 24866961 German.
Cited by
-
Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker.Diagnostics (Basel). 2022 Dec 8;12(12):3096. doi: 10.3390/diagnostics12123096. Diagnostics (Basel). 2022. PMID: 36553103 Free PMC article.
-
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.Eur Respir J. 2022 Jan 27;59(1):2101058. doi: 10.1183/13993003.01058-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34795035 Free PMC article.
-
Carcinoid Tumorlets Co-Existing with Chronic Pulmonary Inflammatory Processes: Imaging Findings and Histological Appearances.Med Sci Monit. 2020 Sep 11;26:e926014. doi: 10.12659/MSM.926014. Med Sci Monit. 2020. PMID: 32913178 Free PMC article.
-
Incidentally Detected Pulmonary Carcinoid Tumorlet With Coexisting Carcinoid Tumorlet in the Mediastinal Lymph Node in a Patient With Lung Cancer.Case Rep Pulmonol. 2025 Aug 21;2025:9910270. doi: 10.1155/crpu/9910270. eCollection 2025. Case Rep Pulmonol. 2025. PMID: 40895606 Free PMC article.
-
Recent advances in the understanding of bronchiolitis in adults.F1000Res. 2020 Jun 8;9:F1000 Faculty Rev-568. doi: 10.12688/f1000research.21778.1. eCollection 2020. F1000Res. 2020. PMID: 32551095 Free PMC article. Review.
References
-
- Walker CM, Vummidi D, Benditt JO, et al. What is DIPNECH? Clin Imaging 2012;36:647–9. - PubMed
-
- Marchevsky AM, Walts AE. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Semin Diagn Pathol 2015;32:438–44. - PubMed
-
- Travis WD, Brambilla E, Burke AP, et al. WHO Classification of Tumours of Lung, Pleura, Thymus and Heart. 2015;Lyon: IARC, 63–85. - PubMed
-
- Wirtschafter E, Walts AE, Liu ST, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia of the lung (DIPNECH); current best evidence. Lung 2015;193:659–67. - PubMed
-
- Stella S, Bruzzese A. Digestive neoplasms of the diffuse neuroendocrine system: physiopathologic and clinical aspects. G Chir 1998;19:5–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical